Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Roblin

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Birth Defects Original Article Series|January 1, 1979
3. Genetic disease as seen on a continuumR Roblin
The Hastings Center Report|August 1, 1975
The Boston XYY caseR Roblin
Federation Proceedings|May 1, 1975
Ethical and social aspects of experimental gene manipulationR Roblin
Science (New York, N.Y.)|March 3, 1972
Gene therapy for human genetic disease?T Friedmann, R Roblin
Cancer Research|August 1, 1980
Dexamethasone regulation of plasminogen activator in embryonic and tumor-derived human cellsR Roblin, P L Young
British Journal of Haematology|July 1, 1984
Differential inhibition of two molecular forms of melanoma cell plasminogen activator by a placental inhibitorI Lecander, R Roblin, B Astedt
Virology|September 1, 1971
Polyoma virus proteins. 1. Multiple virion componentsR Roblin, E Härle, R Dulbecco
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1972
Protein synthesis in Simian virus 40-infected monkey cellsG Walter, R Roblin, R Dulbecco
FEBS Letters|June 30, 1980
The glycoprotein nature of human plasminogen activatorsW L McLellan, D Vetterlein, R Roblin
Journal of Lipid Research|August 1, 1979
Lipids of whole cells and plasma membrane fractions from Balb/c3T3, SV3T3, and concanavalin A-selected revertant cellsS Ruggieri, R Roblin, P H Black
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Birth Defects Original Article Series|January 1, 1979
3. Genetic disease as seen on a continuumR Roblin
The Hastings Center Report|August 1, 1975
The Boston XYY caseR Roblin
Federation Proceedings|May 1, 1975
Ethical and social aspects of experimental gene manipulationR Roblin
Science (New York, N.Y.)|March 3, 1972
Gene therapy for human genetic disease?T Friedmann, R Roblin
Cancer Research|August 1, 1980
Dexamethasone regulation of plasminogen activator in embryonic and tumor-derived human cellsR Roblin, P L Young
British Journal of Haematology|July 1, 1984
Differential inhibition of two molecular forms of melanoma cell plasminogen activator by a placental inhibitorI Lecander, R Roblin, B Astedt
Virology|September 1, 1971
Polyoma virus proteins. 1. Multiple virion componentsR Roblin, E Härle, R Dulbecco
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1972
Protein synthesis in Simian virus 40-infected monkey cellsG Walter, R Roblin, R Dulbecco
FEBS Letters|June 30, 1980
The glycoprotein nature of human plasminogen activatorsW L McLellan, D Vetterlein, R Roblin
Journal of Lipid Research|August 1, 1979
Lipids of whole cells and plasma membrane fractions from Balb/c3T3, SV3T3, and concanavalin A-selected revertant cellsS Ruggieri, R Roblin, P H Black
Pageof 2